Novel players in inflammatory bowel disease pathogenesis

Current Gastroenterology Reports

Volumn 14, Issue 2, 2012, Pages 146-152

  Murphy, Stephen F ^a   Kwon, John H ^a   Boone, David L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

ATG16L1; Autophagy; Crohn's disease; ER Stress; IRGM; Microbiome; NOD2; Novel regulator pathways; Paneth cell; Ulcerative colitis; Unfolded protein response

Indexed keywords

ALANINE; ALPHA DEFENSIN; AUTOPHAGY PROTEIN 16L1; BINDING PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; EPHRIN B1; EPHRIN B3; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MICRORNA; MICRORNA 196; MITOGEN ACTIVATED PROTEIN KINASE; THREONINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX9; TRANSCRIPTION FACTOR TCF4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; ATG16L1 GENE; AUTOPHAGY; CELL TYPE; CROHN DISEASE; CYTOKINE PRODUCTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; EPHB1 GENE; EPHB3 GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; INTESTINE CELL; INTESTINE FLORA; IRGM GENE; MEDICAL RESEARCH; NOD2 GENE; NONHUMAN; PANETH CELL; PATHOGENESIS; SOX9 GENE; ULCERATIVE COLITIS; UNFOLDED PROTEIN RESPONSE;

AUTOPHAGY; HUMANS; INFLAMMATORY BOWEL DISEASES; PANETH CELLS;

EID: 84861100726     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-012-0250-z     Document Type: Article

References (63)

1. Sartor RB, Muehlbauer M. Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr Gastroenterol Rep. 2007;9(6):497-507. (Pubitemid 351795708)
2. Thorbecke GJ, Gordon HA, Wostman B, Wagner M, Reyniers JA. Lymphoid tissue and serum gamma globulin in young germfree chickens. J Infect Dis Nov-Dec. 1957;101(3):237-51.
3. Reyniers JA. The production and use of germ-free animals in experimental biology and medicine. Am J Vet Res. 1957;18 (68):678-87.
4. Pollard M. Germfree animals and biological research. Science. 1964;145(3629):247-51.
5. Hoffmann M, Messlik A, Kim SC, Sartor RB, Haller D. Impact of a probiotic Enterococcus faecalis in a gnotobiotic mouse model of experimental colitis. Mol Nutr Food Res. 2011;55(5):703-13.
6. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science. 2006;313(5790):1126- 30. (Pubitemid 44300239)
7. Vaishnava S, Yamamoto M, Severson KM, et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science. Oct 14 2011;334(6053):255-258.
8. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291(5505):881-4. (Pubitemid 32120760)
9. Xu J, Bjursell MK, Himrod J, et al. A genomic view of the human- Bacteroides thetaiotaomicron symbiosis. Science. 2003;299 (5615):2074-6. (Pubitemid 36383735)
10. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122(1):107-18. (Pubitemid 40977944)
11. Comstock LE, Kasper DL. Bacterial glycans: key mediators of diverse host immune responses. Cell. 2006;126(5):847-50. (Pubitemid 44310786)
12. ChungH,Kasper DL.Microbiota-stimulated immunemechanisms to maintain gut homeostasis. Curr Opin Immunol. 2010;22(4):455-60.
13. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573-621.
14. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780-5. (Pubitemid 350003397)
15. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15 (8):1183-9.
16. Bloom SM, Bijanki VN, Nava GM, et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe. May 19 2011;9(5):390-403.
17. Dicksved J, Halfvarson J, Rosenquist M, et al. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2008;2(7):716-27. (Pubitemid 351951567)
18. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. Jan 22 2009;457 (7228):480-484.
19. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998;66(11):5224-31. (Pubitemid 29044613)
20. Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis. 2010;16(9):1583-97.
21. Rakoff-Nahoum S, Hao L, Medzhitov R. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity. 2006;25 (2):319-29. (Pubitemid 44224143)
22. Carvalho FA, Nalbantoglu I, Ortega-Fernandez S, et al. Interleukin-1{beta} (IL-1{beta}) promotes susceptibility of Tolllike receptor 5 (TLR5) deficient mice to colitis. Gut. Jun 5 2011.
23. Matharu KS, Mizoguchi E, Cotoner CA, et al. Toll-like receptor 4- mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice. Gastroenterology. 2009;137(4):1380-1390-e1381-1383.
24. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest. 2005;115(3):695-702. (Pubitemid 40322244)
25. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118(2):229-41. (Pubitemid 38962578)
26. Lala S, Ogura Y, Osborne C, et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology. 2003;125(1):47-57. (Pubitemid 36799106)
27. Wehkamp J, Harder J, Weichenthal M, et al. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004;53(11):1658-64. (Pubitemid 39434112)
28. Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008;456(7219):259-63.
29. van Es JH, Jay P, Gregorieff A, et al. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol. 2005;7(4):381-6. (Pubitemid 40533127)
30. Bastide P, Darido C, Pannequin J, et al. Sox9 regulates cell proliferation and is required for Paneth cell differentiation in the intestinal epithelium. J Cell Biol. 2007;178(4):635-48. (Pubitemid 47267275)
31. Batlle E, Henderson JT, Beghtel H, et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell. 2002;111(2):251-63. (Pubitemid 35292445)
32. Wehkamp J, Wang G, Kubler I, et al. The Paneth cell alphadefensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf- 4. J Immunol. 2007;179(5):3109-18.
33. Ogura Y, Lala S, XinW, et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut. 2003;52(11):1591-7. (Pubitemid 37363443)
34. Franchi L, Warner N, Viani K, Nunez G. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev. 2009;227(1):106-28.
35. McGovern DP, Hysi P, Ahmad T, et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet. 2005;14(10):1245-50. (Pubitemid 40744484)
36. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411(6837):603-6. (Pubitemid 32531409)
37. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411(6837):599-603. (Pubitemid 32531408)
38. Kobayashi K, Inohara N, Hernandez LD, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 2002;416(6877):194-9. (Pubitemid 34246479)
39. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, Cheng G. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature. 2002;416(6877):190-4. (Pubitemid 34246478)
40. Bouskra D, Brezillon C, Berard M, et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature. 2008;456(7221):507-10. (Pubitemid 352759006)
41. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. Feb 2010;16(2):228-231.
42. Masumoto J, Yang K, Varambally S, et al. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med. 2006;203(1):203-13.
43. Viala J, Chaput C, Boneca IG, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5(11):1166-74. (Pubitemid 39549631)
44. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307(5710):731-4. (Pubitemid 40194644)
45. Maeda S, Hsu LC, Liu H, et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science. 2005;307(5710):734-8. (Pubitemid 40194645)
46. Barreau F, Meinzer U, Chareyre F, et al. CARD15/NOD2 is required for Peyer's patches homeostasis in mice. PLoS One. 2007;2(6):e523.
47. Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science. 2011;334 (6059):1081-6.
48. Kaser A, Lee AH, Franke A, et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell. 2008;134(5):743-56.
49. Rath E, Berger E, Messlik A, et al. Induction of dsRNA-activated protein kinase links mitochondrial unfolded protein response to the pathogenesis of intestinal inflammation. Gut. Oct 13 2011.
50. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007;39(2):207-11. (Pubitemid 46184351)
51. Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol. 2007;7(10):767-77. (Pubitemid 47480305)
52. Bjorkoy G, Lamark T, Brech A, et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 2005;171(4):603-14. (Pubitemid 41668720)
53. Thurston TL, Ryzhakov G, Bloor S, von Muhlinen N, Randow F. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol. 2009;10 (11):1215-21.
54. Saitoh T, Fujita N, Jang MH, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature. 2008;456(7219):264-8.
55. Cadwell K, Patel KK, Maloney NS, et al. Virus-plussusceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell. Jun 25 2010;141 (7):1135-1145.
56. Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. Jan 2010;11(1):55-62.
57. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010;16(1):90-7.
58. Homer CR, Richmond AL, Rebert NA, Achkar JP, McDonald C. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis. Gastroenterology. 2010;139(5):1630-41. 1641 e1631-1632.
59. Kuballa P, Huett A, Rioux JD, Daly MJ, Xavier RJ. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS One. 2008;3(10): e3391.
60. Parkes M, Barrett JC, Prescott NJ, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007;39(7):830-2. (Pubitemid 47014496)
61. McCarroll SA, Huett A, Kuballa P, et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet. 2008;40(9):1107-12.
62. Singh SB, Davis AS, Taylor GA, Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science. 2006;313(5792):1438-41. (Pubitemid 44360272)
63. Brest P, Lapaquette P, Souidi M, et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet. Mar 2011;43(3):242-245.